- €4.55m
- €7.34m
- €14.54m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 14.2 | 16 | 13 | 19.5 | 14.5 |
Cost of Revenue | |||||
Gross Profit | 6.37 | 6.34 | 5.61 | 6.39 | 5.04 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 14.7 | 15.8 | 13.9 | 19.6 | 14.6 |
Operating Profit | -0.499 | 0.206 | -0.898 | -0.096 | -0.051 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.607 | 0.124 | -0.732 | -0.146 | -0.108 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.627 | 0.161 | -0.735 | -0.165 | -0.136 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.627 | 0.16 | -0.735 | -0.167 | -0.134 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.627 | 0.16 | -0.735 | -0.167 | -0.134 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.188 | 0.043 | -0.207 | -0.056 | 0.101 |
Dividends per Share |